Literature DB >> 8971221

The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice.

Z Hasková1, M Filipec, V Holán.   

Abstract

The mouse model of orthotopic corneal transplantation was used to evaluate the clinical course of corneal graft rejection process. Corneal grafts were placed into eyes of naive, unmodified recipients or recipients presensitized with skin graft two weeks before corneal transplantation. Two strain combinations were used, one with genetic disparity at both major and minor histocompatibility antigens and the other with the difference only at multiple minor histocompatibility antigens. A panel of syngeneic graft recipients served as controls. In naive recipients, rejection reaction was recorded in more than 90% of recipients mostly during the third week after grafting and 40-50% of corneas displayed irreversible failure in both strain combinations. Both MHC compatible and incompatible corneal grafts in all presensitized recipients were irreversibly rejected by a second-set allograft reaction. The results thus show an important role of multiple minor histocompatibility antigens in corneal allotransplantation in mice. In addition, the prompt reaction in presensitized recipients is evidence for expression of allotransplantation immunity in the eye, which has been for a long time considered as a privileged site sequestered from systemic immunity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971221

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  3 in total

1.  Evaluation of corneal graft rejection in a mouse model.

Authors:  J Plsková; L Kuffová; V Holán; M Filipec; J V Forrester
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

Review 2.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Lymph node removal enhances corneal graft survival in mice at high risk of rejection.

Authors:  Jarmila Plsková; Vladimír Holán; Martin Filipec; John V Forrester
Journal:  BMC Ophthalmol       Date:  2004-03-23       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.